• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于蛋白质组学数据挖掘的机器学习算法可准确预测乙型肝炎相关肝细胞癌的复发。

Machine learning algorithms based on proteomic data mining accurately predicting the recurrence of hepatitis B-related hepatocellular carcinoma.

作者信息

Feng Gong, He Na, Xia Harry Hua-Xiang, Mi Man, Wang Ke, Byrne Christopher D, Targher Giovanni, Yuan Hai-Yang, Zhang Xin-Lei, Zheng Ming-Hua, Ye Feng

机构信息

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.

出版信息

J Gastroenterol Hepatol. 2022 Nov;37(11):2145-2153. doi: 10.1111/jgh.15940. Epub 2022 Jul 17.

DOI:10.1111/jgh.15940
PMID:35816347
Abstract

BACKGROUND AND AIM

Over 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge about the causes of recurrence and the effective prevention. Prediction of HCC recurrence requires diagnostic markers endowed with high sensitivity and specificity. This study aims to identify new key proteins for HCC recurrence and to build machine learning algorithms for predicting HCC recurrence.

METHODS

The proteomics data for analysis in this study were obtained from the Clinical Proteomics Tumor Analysis Consortium (CPTAC) database. We analyzed different proteins based on cases with or without recurrence of HCC. Survival analysis, Cox regression analysis, and area under the ROC curves (AUROC > 0.7) were used to screen for more significant differential proteins. Predictive models for HCC recurrence were developed using four machine learning algorithms.

RESULTS

A total of 690 differentially expressed proteins between 50 relapsed and 77 non-relapsed hepatitis B-related HCC patients were identified. Seven of these proteins had an AUROC > 0.7 for 5-year survival in HCC, including BAHCC1, ESF1, RAP1GAP, RUFY1, SCAMP3, STK3, and TMEM230. Among the machine learning algorithms, the random forest algorithm showed the highest AUROC values (AUROC: 0.991, 95% CI 0.962-0.999) for identifying HCC recurrence, followed by the support vector machine (AUROC: 0.893, 95% Cl 0.824-0.956), the logistic regression (AUROC: 0.774, 95% Cl 0.672-0.868), and the multi-layer perceptron algorithm (AUROC: 0.571, 95% Cl 0.459-0.682).

CONCLUSIONS

Our study identifies seven novel proteins for predicting HCC recurrence and the random forest algorithm as the most suitable predictive model for HCC recurrence.

摘要

背景与目的

每年超过10%的肝细胞癌(HCC)病例会复发,即使在手术切除后也是如此。目前,对于复发原因及有效预防措施尚缺乏了解。预测HCC复发需要具有高灵敏度和特异性的诊断标志物。本研究旨在识别HCC复发的新关键蛋白,并构建用于预测HCC复发的机器学习算法。

方法

本研究中用于分析的蛋白质组学数据来自临床蛋白质组肿瘤分析联盟(CPTAC)数据库。我们根据HCC有无复发情况分析不同的蛋白质。采用生存分析、Cox回归分析和ROC曲线下面积(AUROC>0.7)来筛选更显著的差异蛋白。使用四种机器学习算法开发HCC复发的预测模型。

结果

在50例复发和77例未复发的乙型肝炎相关HCC患者之间共鉴定出690种差异表达蛋白。其中7种蛋白在HCC患者5年生存中的AUROC>0.7,包括BAHCC1、ESF1、RAP1GAP、RUFY1、SCAMP3、STK3和TMEM230。在机器学习算法中,随机森林算法在识别HCC复发方面显示出最高的AUROC值(AUROC:0.991,95%CI 0.962 - 0.999),其次是支持向量机(AUROC:0.893,95%Cl 0.824 - 0.956)、逻辑回归(AUROC:0.774,95%Cl 0.672 - 0.868)和多层感知器算法(AUROC:0.571,95%Cl 0.459 - 0.682)。

结论

我们的研究识别出7种预测HCC复发的新蛋白,且随机森林算法是最适合HCC复发的预测模型。

相似文献

1
Machine learning algorithms based on proteomic data mining accurately predicting the recurrence of hepatitis B-related hepatocellular carcinoma.基于蛋白质组学数据挖掘的机器学习算法可准确预测乙型肝炎相关肝细胞癌的复发。
J Gastroenterol Hepatol. 2022 Nov;37(11):2145-2153. doi: 10.1111/jgh.15940. Epub 2022 Jul 17.
2
Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis.新型机器学习模型在预测慢性病毒性肝炎患者的肝细胞癌方面优于风险评分。
JHEP Rep. 2022 Jan 22;4(3):100441. doi: 10.1016/j.jhepr.2022.100441. eCollection 2022 Mar.
3
Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.基于增强 CT 影像组学的机器学习分析预测肝癌切除术后复发:多中心研究。
EBioMedicine. 2019 Dec;50:156-165. doi: 10.1016/j.ebiom.2019.10.057. Epub 2019 Nov 15.
4
Machine Learning Prediction Models for Diagnosing Hepatocellular Carcinoma with HCV-related Chronic Liver Disease.用于诊断丙型肝炎病毒相关慢性肝病合并肝细胞癌的机器学习预测模型
Comput Methods Programs Biomed. 2020 Nov;196:105551. doi: 10.1016/j.cmpb.2020.105551. Epub 2020 May 23.
5
Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma.机器学习算法在预测肝细胞癌的发生方面优于传统的回归模型。
Am J Gastroenterol. 2013 Nov;108(11):1723-30. doi: 10.1038/ajg.2013.332. Epub 2013 Oct 29.
6
Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNA-Seq datasets and machine learning.利用 RNA-Seq 数据集和机器学习技术鉴定肝细胞癌(HCC)的新型转录生物标志物。
BMC Cancer. 2021 Aug 27;21(1):962. doi: 10.1186/s12885-021-08704-9.
7
Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma.基于机器学习的肝癌术后早期复发风险预测模型的建立。
World J Gastroenterol. 2023 Nov 21;29(43):5804-5817. doi: 10.3748/wjg.v29.i43.5804.
8
Diagnosis of hepatocellular carcinoma based on salivary protein glycopatterns and machine learning algorithms.基于唾液蛋白糖谱和机器学习算法的肝细胞癌诊断。
Clin Chem Lab Med. 2022 Sep 19;60(12):1963-1973. doi: 10.1515/cclm-2022-0715. Print 2022 Nov 25.
9
Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine.利用机器学习进行肝细胞癌早期复发预测:迈向精准医学的一步。
World J Gastroenterol. 2024 Feb 7;30(5):424-428. doi: 10.3748/wjg.v30.i5.424.
10
From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring.从预测到预防:机器学习引发肝细胞癌复发监测革命。
World J Gastroenterol. 2024 Feb 21;30(7):631-635. doi: 10.3748/wjg.v30.i7.631.

引用本文的文献

1
A nomograph model for predicting the risk of diabetes nephropathy.一种用于预测糖尿病肾病风险的列线图模型。
Int Urol Nephrol. 2025 Jun;57(6):1919-1931. doi: 10.1007/s11255-024-04351-8. Epub 2025 Jan 8.
2
ESF1 and MIPEP proteins promote estrogen receptor-positive breast cancer proliferation and are associated with patient prognosis.ESF1和MIPEP蛋白促进雌激素受体阳性乳腺癌的增殖,并与患者预后相关。
Clin Proteomics. 2024 Jul 15;21(1):50. doi: 10.1186/s12014-024-09502-8.
3
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy.
用于预测肿瘤免疫检查点抑制剂疗效的生物标志物和计算模型。
Front Immunol. 2024 Mar 8;15:1368749. doi: 10.3389/fimmu.2024.1368749. eCollection 2024.
4
Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells.揭示宫颈癌的诊断和治疗策略:通过蛋白质组学方法发现生物标志物并探索宫颈癌干细胞的作用。
Front Oncol. 2024 Jan 24;13:1277772. doi: 10.3389/fonc.2023.1277772. eCollection 2023.
5
Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center study.基于机器学习的肝细胞癌治疗推荐和总生存预测临床决策支持系统:一项多中心研究
NPJ Digit Med. 2024 Jan 5;7(1):2. doi: 10.1038/s41746-023-00976-8.
6
Revisiting artificial intelligence diagnosis of hepatocellular carcinoma with DIKWH framework.用DIKWH框架重新审视肝细胞癌的人工智能诊断
Front Genet. 2023 Mar 7;14:1004481. doi: 10.3389/fgene.2023.1004481. eCollection 2023.
7
MP-VHPPI: Meta predictor for viral host protein-protein interaction prediction in multiple hosts and viruses.MP-VHPPI:用于多宿主和病毒中病毒宿主蛋白质-蛋白质相互作用预测的元预测器
Front Med (Lausanne). 2022 Nov 16;9:1025887. doi: 10.3389/fmed.2022.1025887. eCollection 2022.